{"gene":"PDX1","run_date":"2026-04-29T11:37:58","timeline":{"discoveries":[{"year":1996,"finding":"PDX-1 (mouse pdx-1) is required for pancreatic outgrowth and differentiation; null mutation leads to apancreatic mice with only limited dorsal bud outgrowth lacking insulin/amylase-positive cells, demonstrating PDX-1 is essential for pancreatic progenitor proliferation and differentiation.","method":"Gene targeting (knockout mouse), histology, immunostaining, lacZ reporter fusion","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 — constitutive knockout with rigorous developmental phenotyping, replicated across two independent null alleles","pmids":["8631275"],"is_preprint":false},{"year":1995,"finding":"PDX-1/STF-1 binds cooperatively with the homeodomain cofactor Pbx to regulatory elements in the somatostatin promoter; cooperative binding requires both the conserved N-terminal FPWMK pentapeptide motif and the N-terminal arm of the PDX-1 homeodomain.","method":"In vitro DNA-binding assays, co-immunoprecipitation, mutational analysis of FPWMK motif and homeodomain","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted cooperative DNA binding in vitro with domain mutagenesis","pmids":["8524276"],"is_preprint":false},{"year":1997,"finding":"PDX-1 transactivation is mediated by three conserved N-terminal subdomains (amino acids 13-22, 32-38, 60-73); these same sequences are required for synergistic activation of insulin gene transcription with E2A-encoded bHLH proteins.","method":"GAL4-chimera transactivation assays, deletion/point mutagenesis, stable expression in betaTC3 cells","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1 — detailed mutagenesis with multiple functional readouts in beta-cell lines","pmids":["9199333"],"is_preprint":false},{"year":1997,"finding":"PDX-1/STF-1 gene expression in pancreatic islets requires an E-box element at -104 bp recognized by the helix-loop-helix/leucine zipper factor USF; point mutations disrupting USF binding impair STF-1 promoter activity in transgenic mice.","method":"Transgenic reporter mice, site-directed mutagenesis, EMSA","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — transgenic reporter + mutagenesis with in vivo validation","pmids":["8567692"],"is_preprint":false},{"year":1997,"finding":"PDX-1 (IDX-1) protein is markedly reduced (~80%) in islets from partially pancreatectomized hyperglycemic rats, coinciding with reduced GLUT2 and insulin mRNAs, suggesting PDX-1 loss mediates transcriptional dysfunction during chronic hyperglycemia.","method":"Western blot, quantitative RT-PCR, immunofluorescence on isolated islets","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical methods in a defined in vivo model; single lab, correlational","pmids":["9000703"],"is_preprint":false},{"year":1997,"finding":"HNF-3β activates and glucocorticoids repress PDX-1/STF-1 gene expression through a composite islet-specific enhancer; overexpression of HNF-3β suppresses glucocorticoid receptor-mediated inhibition of PDX-1 transcription.","method":"Transfection reporter assays, EMSA, overexpression in islet cell lines","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 — functional dissection with multiple regulatory elements; single lab","pmids":["9111329"],"is_preprint":false},{"year":1999,"finding":"PDX-1 bears a nuclear localization signal (NLS) that resides within helix 3 of the homeodomain; point mutations of basic residues in helix 3 abolish nuclear transport, identifying a novel class of NLS.","method":"EGFP-tagged deletion/point mutant constructs expressed in COS-7 cells, fluorescence microscopy, Western blot","journal":"European Journal of Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with direct subcellular localization readout","pmids":["10429201"],"is_preprint":false},{"year":1999,"finding":"PDX1 and Pbx-Prep1 heterodimeric complex cooperatively activate the somatostatin mini-enhancer; Pbx1 and Prep1 bind cooperatively to the UE-A element and require co-expression of PDX1 binding to the adjacent TSEI element for strong transcriptional activation.","method":"EMSA with recombinant proteins, transient transfection reporter assays","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted cooperative DNA binding with recombinant proteins plus functional reporter assays","pmids":["9933599"],"is_preprint":false},{"year":1999,"finding":"Pax6 and PDX1 form a functional complex on the somatostatin upstream enhancer; PDX1 potentiates Pax6-mediated activation, and simultaneous binding of PDX1 to the B-element and Pax6 to the C-element is required for beta/delta-cell-specific activity.","method":"EMSA, transient transfection reporter assays, site-directed mutagenesis","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA binding + functional reporter with mutagenesis; single lab","pmids":["10094480"],"is_preprint":false},{"year":2000,"finding":"PDX-1, BETA2/NeuroD, and E2A co-expressed in non-beta cells synergistically activate the insulin promoter ~160-fold; PDX-1 alone produces only modest activation, demonstrating that high-level insulin transcription requires cooperative interaction of all three factors.","method":"Transfection of non-beta cells with combinations of transcription factors, reporter gene assays","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic combinatorial overexpression with defined promoter readout","pmids":["10636926"],"is_preprint":false},{"year":2000,"finding":"The PDX-1 transactivation domain confers beta-cell-specific and glucose-responsive activation of the insulin gene through cooperative interactions with other enhancer-bound factors (E1 element activators); heterologous activation domains (VP16, E1A) cannot substitute functionally.","method":"GAL4-substituted insulin enhancer reporter assays in beta-cell and non-beta-cell lines, mutagenesis","journal":"Molecular Endocrinology","confidence":"High","confidence_rationale":"Tier 1 — detailed structure-function analysis with multiple chimeras and mutants","pmids":["11117522"],"is_preprint":false},{"year":2002,"finding":"Haploinsufficiency for PDX-1 impairs glucose-stimulated insulin secretion in mice by reducing PDX-1 and GLUT2 expression, diminishing NAD(P)H generation (~30%), and impairing mitochondrial function and intracellular Ca2+ mobilization in beta cells.","method":"PDX-1+/- mice, perfused pancreas secretion assays, NAD(P)H imaging, Western blot, glucose tolerance testing","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal physiological and biochemical methods in a defined genetic model","pmids":["11781323"],"is_preprint":false},{"year":2002,"finding":"PDX-1 is modified by SUMO-1 in beta cells; this sumoylation contributes to the molecular mass shift from 31 to 46 kDa, promotes nuclear localization and stability of PDX-1, and is required for full insulin gene transcriptional activity.","method":"Transfection, co-immunoprecipitation, RNA interference against SUMO-1, proteasome inhibitor treatment, reporter assays","journal":"American Journal of Physiology - Endocrinology and Metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods including RNAi and pharmacological inhibition; single lab","pmids":["12488243"],"is_preprint":false},{"year":2002,"finding":"Transgenic expression of Pdx1 rescues beta cell mass and function and prevents diabetes in Irs2-/- mice, demonstrating that Pdx1 acts downstream of IRS2 signaling to maintain beta cell mass; Pdx1 haploinsufficiency accelerates diabetes onset in Irs2-/- mice.","method":"Genetic epistasis (Irs2-/- x Pdx1 transgenic and Pdx1+/- mice), glucose tolerance, histology","journal":"The Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 2 — clean genetic epistasis with multiple intersecting alleles and defined functional readouts","pmids":["11994408"],"is_preprint":false},{"year":2003,"finding":"PDX-1 is translocated from nucleus to cytoplasm in response to oxidative stress via a JNK-dependent mechanism; a nuclear export signal (NES) was identified at amino acids 82-94 of mouse PDX-1 that overrides the NLS, and this translocation is blocked by leptomycin B or dominant-negative JNK.","method":"Live-cell imaging of GFP-PDX-1, dominant-negative JNK expression, leptomycin B treatment, NES identification by deletion mapping in HIT-T15 cells","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1 — mechanistic identification of NES, live imaging, pharmacological and genetic dissection of JNK pathway","pmids":["14633849"],"is_preprint":false},{"year":2003,"finding":"Increased Pdx1+/- beta cell apoptosis (with reduced Bcl-XL and Bcl-2), abnormal islet architecture, and failure of beta cell mass expansion with age underlie the organ-level insulin secretion defect in Pdx1 heterozygous mice.","method":"TUNEL, active caspase-3 staining, Ca2+ imaging, single-cell patch-clamp, Western blot for Bcl-XL/Bcl-2 in Pdx1+/- islets","journal":"The Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (TUNEL, caspase-3, electrophysiology, Western blot) in a defined genetic model","pmids":["12697734"],"is_preprint":false},{"year":2004,"finding":"PCIF1/SPOP, a POZ domain protein, interacts with the C-terminus of PDX-1 both in vitro and in vivo; coexpression of PCIF1 alters subnuclear distribution of PDX-1 and inhibits PDX-1 transactivation of target gene promoters in a C-terminus-dependent manner.","method":"Yeast two-hybrid (identification), co-immunoprecipitation, reporter assays, overexpression in MIN6 cells","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal binding demonstrated plus functional reporter assays; single lab","pmids":["15121856"],"is_preprint":false},{"year":2005,"finding":"Pdx-1 links histone H3-Lys-4 dimethylation to RNA polymerase II elongation at the insulin gene; Pdx-1 directly interacts with the methyltransferase Set9 (co-IP), recruits Set9 to the insulin promoter, and Pdx-1 knockdown reduces H3-Lys-4 dimethylation and shifts pol II from elongation to initiation isoform at the insulin locus.","method":"siRNA knockdown, chromatin immunoprecipitation (ChIP), co-immunoprecipitation (Pdx-1 and Set9), immunohistochemistry","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct interaction by co-IP plus ChIP-based mechanistic dissection with siRNA","pmids":["16141209"],"is_preprint":false},{"year":2006,"finding":"Persistent/constitutive PDX-1 expression in all pancreatic lineages causes acinar-to-ductal metaplasia through cell-autonomous activation of Stat3; genetic ablation of Stat3 in the transgenic pancreas profoundly suppresses the metaplastic phenotype.","method":"Transgenic overexpression (CAG-PDX1), genetic Stat3 knockout epistasis, histology","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with clean phenotypic rescue; replicated in vivo","pmids":["16751181"],"is_preprint":false},{"year":2007,"finding":"PDX-1 identifies and directly activates the TFAM (mitochondrial transcription factor A) gene in beta cells; PDX-1 deficiency reduces TFAM expression, decreases mtDNA copy number and respiratory chain activity, and impairs ATP synthesis and glucose-stimulated insulin secretion; adenoviral TFAM restoration rescues these defects.","method":"Dominant-negative Pdx1 adenovirus, transcript profiling, ChIP (PDX-1 occupancy at TFAM), adenoviral TFAM rescue in rat islets, mtDNA measurement","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 1 — ChIP demonstrating direct occupancy of TFAM promoter, gene rescue by adenoviral TFAM, multiple orthogonal methods","pmids":["19656489"],"is_preprint":false},{"year":2009,"finding":"Pdx1 regulates beta cell susceptibility to ER stress; Pdx1-deficient beta cells show ER stress markers and enhanced ER stress-associated apoptosis; chromatin occupancy and expression microarray analysis reveal that Pdx1 directly regulates a broad set of ER function genes including those involved in disulfide bond formation, protein folding, and the unfolded protein response.","method":"High-fat diet Pdx1+/- model, Min6 siRNA knockdown, chromatin occupancy ChIP, expression microarray, ER stress markers","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 — ChIP + microarray + defined genetic model with multiple orthogonal methods","pmids":["19855005"],"is_preprint":false},{"year":2009,"finding":"Increased autophagy contributes to Pdx1-deficiency-induced beta cell death; inhibition of autophagy (pharmacological or Becn1 haploinsufficiency) prolongs survival of Pdx1-deficient MIN6 cells and improves glucose tolerance and beta cell mass in Pdx1+/- mice on high-fat diet.","method":"Lentiviral shRNA knockdown of Pdx1 in MIN6, autophagy inhibitors, Pdx1+/- x Becn1+/- genetic cross, metabolic testing","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis and pharmacological rescue; single lab","pmids":["19654319"],"is_preprint":false},{"year":2010,"finding":"Protein kinase CK2 phosphorylates Pdx-1 at Thr231 and Ser232, and this phosphorylation regulates the transcriptional activity of Pdx-1 at the insulin promoter; inhibition of CK2 elevates insulin release from pancreatic beta cells.","method":"In vitro kinase assay with Pdx-1 fragments, phosphorylation site mutagenesis, insulin promoter reporter assays, CK2 inhibitor treatment","journal":"Cellular and Molecular Life Sciences","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro kinase assay with mutagenesis plus functional reporter; single lab","pmids":["20339896"],"is_preprint":false},{"year":2011,"finding":"The retinoblastoma protein RB associates with and stabilizes Pdx-1 through a conserved RB-interaction motif (RIM) in Pdx-1; point mutations in the RIM reduce RB-Pdx-1 complex formation and promote proteasomal degradation of Pdx-1; RB occupies promoters of beta-cell-specific genes and RB deficiency reduces Pdx-1 expression and pancreas size in vivo.","method":"Co-immunoprecipitation, point mutagenesis of RIM, proteasome inhibitor experiments, ChIP, RB conditional knockout mice","journal":"The EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 — direct binding by co-IP, mutagenesis of interaction motif, in vivo genetic validation","pmids":["21399612"],"is_preprint":false},{"year":2011,"finding":"Forced Pdx1 expression from the Neurogenin-3 stage onward causes postnatal conversion of alpha cells (glucagon/Arx-positive) through a glucagon-insulin double-positive intermediate to cells indistinguishable from normal beta cells; this context-dependent reprogramming requires Pdx1 activity in Neurog3+ cells but not in mature glucagon-expressing cells.","method":"Conditional Pdx1 transgene (Neurog3-Cre driver), lineage tracing, immunostaining, genetic epistasis","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 — conditional genetic approach with lineage tracing; clean phenotypic characterization","pmids":["21852533"],"is_preprint":false},{"year":2012,"finding":"Genome-wide ChIP-seq of Pdx1 in human and mouse islets identifies a conserved cistrome enriched for genes involved in endocrine function, metabolic disorders, signaling pathways, and cell survival, defining the direct transcriptional targets mediating Pdx1's role in islet function.","method":"ChIP-seq in human and mouse islets, evolutionary conservation analysis","journal":"Molecular Endocrinology","confidence":"High","confidence_rationale":"Tier 1 — genome-wide chromatin occupancy in primary tissue from two species","pmids":["22322596"],"is_preprint":false},{"year":2015,"finding":"Pdx1 regulates mitophagy in pancreatic beta cells through transcriptional control of Clec16a and its downstream target Nrdp1 (E3 ubiquitin ligase); loss of Pdx1 impairs autophagosome-lysosome fusion during mitophagy, and restoration of Clec16a rescues mitochondrial trafficking, respiration, and glucose-stimulated insulin secretion.","method":"ChIP-seq (Pdx1 occupancy at Clec16a), expression microarray, adenoviral Clec16a rescue, mitophagy flux assays, Pdx1+/- islets","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1 — ChIP-seq plus adenoviral rescue of downstream pathway with functional mitophagy readout","pmids":["26085571"],"is_preprint":false},{"year":2015,"finding":"Pdx1 and Sox9 cooperatively bind regulatory sequences near pancreatic and intestinal differentiation genes, jointly activating pancreatic lineage genes and repressing the intestinal lineage; genetic studies show dual and cooperative roles for both factors in pancreatic lineage induction.","method":"ChIP-seq (Pdx1 and Sox9 occupancy), genetic epistasis with conditional knockouts, gene expression analysis","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 1 — genome-wide ChIP-seq plus genetic epistasis in vivo","pmids":["26440894"],"is_preprint":false},{"year":2015,"finding":"Pdx1 directly binds and activates the E-cadherin (Cdh1) promoter via two conserved binding sites; Pdx1 is required in vivo for maintenance of E-cadherin expression, actomyosin complex activity, and epithelial cell shape during pancreatic tubulogenesis.","method":"ChIP (Pdx1 at E-cad promoter), reporter assays, Pdx1-/- mouse embryo analysis, immunostaining","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 — direct ChIP plus reporter assays plus in vivo genetic phenotyping","pmids":["26657766"],"is_preprint":false},{"year":2018,"finding":"SPOP (PCIF1) binds directly to Pdx1 residues 223-233 with low micromolar affinity via its MATH domain; the SPOP-Pdx1 crystal structure shows an extended interface; phosphorylation of Pdx1 within this region reduces its affinity for SPOP, providing a regulatory mechanism controlling Pdx1 ubiquitination and proteasomal degradation.","method":"Crystal structure of SPOP-Pdx1 complex, isothermal titration calorimetry (ITC), NMR spectroscopy","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with ITC and NMR validation of phosphorylation-dependent binding","pmids":["30449689"],"is_preprint":false},{"year":2018,"finding":"PDX1 forms stress-inducible complexes with ATF4 and ATF5 in beta cells; these complexes co-occupy composite C/EBP-ATF (CARE) motifs at stress and apoptosis genes (including Gpt2, Chac1, Slc7a1); PDX1-ATF complex governs beta cell survival, and deficiency of Gpt2 reduces stress-induced apoptosis.","method":"Co-immunoprecipitation, ChIP-seq, RNAseq (shRNA knockdown of Pdx1, Atf4, Atf5), caspase-3 activation assay","journal":"Molecular Metabolism","confidence":"High","confidence_rationale":"Tier 1 — co-IP, ChIP-seq, and RNAseq with downstream gene knockout validation","pmids":["30174228"],"is_preprint":false},{"year":2019,"finding":"GSK3 kinase phosphorylates Pdx1 in diabetic islets; pharmacological GSK3 inhibition rescues glucose-stimulated insulin secretion in human islets under glucotoxicity, identifying GSK3-PDX1 as a key pathogenic signaling axis.","method":"Mass spectrometry-based phosphoproteomics of diabetic mouse islets, GSK3 inhibitor treatment of human islets, GSIS assays","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 1 — quantitative phosphoproteomics plus pharmacological rescue with functional readout; replicated in human islets","pmids":["30879985"],"is_preprint":false},{"year":2019,"finding":"Point mutations in the PDX1 transactivation domain (P33T, C18R) impair beta-cell differentiation and function; iPSC modeling shows these mutations reduce expression of PDX1-bound target genes including MNX1, PDX1 itself (autoregulation), and MEG3/NNAT in pancreatic progenitors.","method":"iPSC lines with engineered mutations, beta-cell differentiation protocol, ChIP-seq (PDX1 occupancy), RNA expression profiling","journal":"Molecular Metabolism","confidence":"High","confidence_rationale":"Tier 1 — isogenic iPSC models with ChIP-seq and transcriptomics; human disease mutations validated","pmids":["30930126"],"is_preprint":false},{"year":2021,"finding":"Saturated fatty acids (palmitic acid) trap PDX1 in cytoplasmic stress granules in beta cells by disrupting nucleocytoplasmic transport via a PI3K/EIF2α-dependent mechanism; PDX1 was identified as a stress granule component by mass spectrometry; disruption of stress granule assembly (PI3K/EIF2α inhibitors or TIA1 deletion) restores PDX1 nuclear localization and ameliorates beta cell dysfunction.","method":"Mass spectrometry of stress granule components, immunofluorescence, nucleocytoplasmic transport reporters, PI3K/EIF2α inhibitors, TIA1 knockout mice","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 1 — MS identification plus genetic deletion plus pharmacological rescue with functional readout","pmids":["33569632"],"is_preprint":false},{"year":2021,"finding":"OGT (O-GlcNAc transferase) regulates beta cell mitochondrial morphology and bioenergetics partly through Pdx1; constitutive OGT deletion reduces Pdx1 levels, and overexpression of Pdx1 in OGT-deficient islets rescues mitochondrial morphology, insulin content, and mitochondrial function.","method":"Conditional OGT knockout mice, islet proteomics, adenoviral Pdx1 overexpression rescue, oxygen consumption rate assay","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — genetic model with adenoviral rescue, but OGT-Pdx1 direct biochemical link not shown","pmids":["34462257"],"is_preprint":false},{"year":2024,"finding":"PDX1 silences NF-κB at circadian and inflammatory enhancers in beta cells through long-range chromatin contacts involving SIN3A; PDX1 hypomorphic mice show de-repression of NF-κB and impaired nocturnal glucose tolerance; Bmal1 ablation disrupts genome-wide PDX1 and NF-κB DNA binding, and antagonizing the IL-1β receptor (NF-κB target) improves insulin secretion in Pdx1 hypomorphic islets.","method":"Single-cell ATAC-seq atlas of human islets, ChIP-seq, 3D chromatin analysis (Hi-C/proximity ligation), Pdx1 hypomorphic mice, Bmal1 beta-cell knockout, pharmacological IL-1β receptor antagonism","journal":"Cell Metabolism","confidence":"High","confidence_rationale":"Tier 1 — ChIP-seq, 3D chromatin structure, single-cell epigenomics, and genetic + pharmacological rescue","pmids":["38171340"],"is_preprint":false},{"year":2009,"finding":"E178G substitution in the PDX1 homeodomain causes neonatal diabetes by reducing Pdx1 transactivation activity despite normal nuclear localization, expression level, and chromatin occupancy, demonstrating that homeodomain integrity is required for transcriptional activation independently of DNA binding.","method":"Genetic analysis of consanguineous family, recombinant protein functional assays (transcriptional activation, nuclear localization, chromatin occupancy) in cell lines","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical functional assays with disease mutation; single lab","pmids":["20009086"],"is_preprint":false}],"current_model":"PDX1 is a homeodomain transcription factor that acts as a master regulator of pancreatic development and adult beta-cell function: it binds insulin, somatostatin, IAPP, GLUT2, glucokinase, TFAM, E-cadherin, Clec16a, and other target gene promoters (directly demonstrated by ChIP), recruits coactivators including the H3K4 methyltransferase Set9 to drive RNA pol II elongation, forms cooperative complexes with Pbx, Prep1, Pax6, BETA2/E2A, MafA, HMGA1, ATF4/ATF5 and is stabilized by RB interaction; its nuclear localization is regulated by SUMO-1 modification, JNK-dependent nuclear export via a defined NES, trapping in stress granules by saturated fatty acids, and GSK3/CK2 phosphorylation; SPOP/PCIF1 targets PDX1 for proteasomal degradation via a phosphorylation-sensitive MATH-domain interaction; complete PDX1 loss causes pancreatic agenesis, haploinsufficiency impairs beta-cell mass, ER function, mitophagy (via Clec16a-Nrdp1), and mitochondrial biogenesis (via TFAM), and high PDX1 induces acinar-to-ductal metaplasia through Stat3 activation."},"narrative":{"teleology":[{"year":1995,"claim":"Before this work it was unknown how PDX1 achieved target-gene specificity; demonstration that PDX1 forms cooperative DNA-binding complexes with Pbx via its conserved FPWMK pentapeptide and homeodomain N-terminal arm established the cofactor-dependent binding paradigm for PDX1 target selection.","evidence":"In vitro DNA-binding assays, co-IP, and FPWMK/homeodomain mutagenesis on somatostatin promoter elements","pmids":["8524276"],"confidence":"High","gaps":["Structural basis of Pbx–PDX1 cooperative complex not resolved","In vivo relevance of FPWMK motif not tested genetically"]},{"year":1996,"claim":"Whether PDX1 was essential for pancreas formation was unresolved; knockout mice lacking pdx-1 showed pancreatic agenesis with only rudimentary dorsal bud outgrowth, establishing PDX1 as indispensable for pancreatic progenitor proliferation and differentiation.","evidence":"Gene targeting (constitutive knockout mouse), histology, immunostaining, lacZ reporter","pmids":["8631275"],"confidence":"High","gaps":["Cell-autonomous versus non-autonomous roles not distinguished","Which downstream targets mediate pancreatic outgrowth arrest unknown"]},{"year":1997,"claim":"The structural basis for PDX1 transactivation was undefined; mapping identified three conserved N-terminal subdomains required for synergistic insulin promoter activation with E2A bHLH factors, and upstream USF/E-box-dependent regulation of the PDX1 gene itself was demonstrated in vivo.","evidence":"GAL4-chimera mutagenesis in betaTC3, transgenic reporter mice with USF site mutations","pmids":["9199333","8567692"],"confidence":"High","gaps":["Identity of all cofactors engaging the three subdomains unknown","Whether USF is the sole upstream regulator in vivo untested"]},{"year":1999,"claim":"How PDX1 reaches the nucleus was unknown; identification of a novel NLS within homeodomain helix 3, plus reconstitution of cooperative Pbx1–Prep1–PDX1 and Pax6–PDX1 complexes on the somatostatin enhancer, defined the nuclear targeting and combinatorial logic of PDX1 at endocrine-specific genes.","evidence":"GFP-tagged deletion/point mutants in COS-7 cells; EMSA with recombinant Pbx1/Prep1/PDX1; reporter assays with Pax6","pmids":["10429201","9933599","10094480"],"confidence":"High","gaps":["NLS importin partner not identified","Relative contribution of each cofactor complex in vivo unknown"]},{"year":2000,"claim":"Whether PDX1 alone could activate high-level insulin transcription was unclear; combinatorial expression showed that PDX1 with BETA2/NeuroD and E2A synergistically activated insulin ~160-fold, and that the PDX1 transactivation domain confers beta-cell-specific, glucose-responsive activity that heterologous activation domains cannot replace.","evidence":"Combinatorial transfection in non-beta cells; GAL4-substituted enhancer reporters in beta and non-beta lines","pmids":["10636926","11117522"],"confidence":"High","gaps":["Glucose-sensing mechanism of PDX1 transactivation domain unresolved","Direct physical contacts between PDX1 and BETA2 not mapped"]},{"year":2002,"claim":"The in vivo consequences of partial PDX1 loss were uncharacterized; haploinsufficient mice showed impaired GSIS, reduced GLUT2, defective mitochondrial NAD(P)H generation, increased beta-cell apoptosis with reduced Bcl-XL/Bcl-2, and failure of beta-cell mass expansion, while SUMO-1 modification was shown to promote PDX1 nuclear retention and transcriptional activity.","evidence":"Pdx1+/- mice with perfused pancreas, NAD(P)H imaging, TUNEL, caspase-3, Western blot; co-IP and RNAi for SUMO-1 in beta cells","pmids":["11781323","12697734","12488243"],"confidence":"High","gaps":["SUMO-1 conjugation site(s) on PDX1 not mapped","Whether apoptosis is cell-autonomous or secondary to metabolic stress unclear"]},{"year":2002,"claim":"The signaling pathways upstream of PDX1 in beta-cell mass regulation were unknown; genetic epistasis showed that Pdx1 transgene rescues beta-cell mass and prevents diabetes in Irs2-/- mice, placing PDX1 downstream of IRS2/insulin signaling.","evidence":"Irs2-/- × Pdx1 transgenic and Pdx1+/- genetic crosses, glucose tolerance, histology","pmids":["11994408"],"confidence":"High","gaps":["Biochemical mechanism linking IRS2 signaling to PDX1 expression/stability not defined"]},{"year":2003,"claim":"How oxidative stress impairs PDX1 function was unknown; identification of a functional NES (aa 82–94) and demonstration that JNK-dependent phosphorylation triggers CRM1-mediated nuclear export of PDX1 established a regulated nucleo-cytoplasmic shuttling mechanism.","evidence":"GFP-PDX1 live imaging, leptomycin B blockade, dominant-negative JNK, NES deletion mapping in HIT-T15 cells","pmids":["14633849"],"confidence":"High","gaps":["Specific JNK phosphorylation site(s) on PDX1 not identified","Whether this mechanism operates in human islets not tested"]},{"year":2004,"claim":"The degradation machinery for PDX1 was unidentified; PCIF1/SPOP was discovered as a PDX1-interacting protein that alters its subnuclear distribution and inhibits its transactivation, initiating understanding of PDX1 proteostasis.","evidence":"Yeast two-hybrid identification, co-IP, reporter assays in MIN6","pmids":["15121856"],"confidence":"Medium","gaps":["Whether SPOP mediates PDX1 ubiquitination and degradation not directly shown at this stage","Endogenous interaction stoichiometry unknown"]},{"year":2005,"claim":"The chromatin mechanism by which PDX1 activates insulin transcription was unknown; PDX1 was shown to recruit the H3K4 methyltransferase Set9 to the insulin promoter, linking PDX1 occupancy to histone methylation and RNA pol II elongation.","evidence":"Co-IP of PDX1–Set9, ChIP for H3K4me2 and pol II isoforms, siRNA knockdown of PDX1","pmids":["16141209"],"confidence":"High","gaps":["Whether Set9 is required for all PDX1 target genes or only insulin unknown","Structural basis of PDX1–Set9 interaction unresolved"]},{"year":2006,"claim":"Consequences of ectopic/sustained PDX1 expression were undefined; constitutive PDX1 in all pancreatic lineages caused acinar-to-ductal metaplasia through cell-autonomous Stat3 activation, revealing a dosage-dependent oncogenic potential.","evidence":"Transgenic CAG-PDX1 mice, genetic Stat3 knockout epistasis, histology","pmids":["16751181"],"confidence":"High","gaps":["How PDX1 activates Stat3 (direct transcriptional target vs. signaling) not resolved","Relevance to human pancreatic cancer initiation uncertain"]},{"year":2009,"claim":"PDX1's role beyond insulin gene regulation in beta-cell homeostasis was unclear; three studies collectively showed that PDX1 directly activates TFAM to maintain mitochondrial biogenesis and respiration, regulates a broad ER function gene program protecting against ER stress, and that excessive autophagy contributes to Pdx1-deficient beta-cell death.","evidence":"ChIP at TFAM promoter with adenoviral TFAM rescue; ChIP + microarray in Pdx1+/- and Min6 siRNA; Pdx1+/- × Becn1+/- genetic cross with autophagy inhibitors","pmids":["19656489","19855005","19654319"],"confidence":"High","gaps":["Whether ER stress and mitochondrial defects are independent or interconnected consequences of PDX1 loss not resolved","Autophagy pathway specificity not defined"]},{"year":2009,"claim":"Whether homeodomain integrity is needed for PDX1 transactivation independently of DNA binding was untested; the E178G neonatal-diabetes mutation was shown to impair transactivation without affecting nuclear localization or chromatin occupancy, dissociating binding from activation.","evidence":"Genetic analysis of consanguineous family; recombinant protein functional assays in cell lines","pmids":["20009086"],"confidence":"Medium","gaps":["Mechanism by which E178G disrupts transactivation despite normal occupancy unknown","Single family reported"]},{"year":2010,"claim":"Post-translational regulation of PDX1 by kinases beyond JNK was poorly characterized; CK2 was identified as a kinase phosphorylating PDX1 at Thr231/Ser232, modulating insulin promoter activity.","evidence":"In vitro kinase assay, phosphosite mutagenesis, insulin promoter reporters, CK2 inhibitor","pmids":["20339896"],"confidence":"Medium","gaps":["In vivo relevance of CK2 phosphorylation not validated","Interplay with SPOP degron phosphorylation not examined"]},{"year":2011,"claim":"How PDX1 protein stability is maintained was unclear; RB was found to bind PDX1 via a conserved RB-interaction motif, stabilizing it against proteasomal degradation, and forced Pdx1 expression from the Neurog3 stage was shown to convert alpha cells to functional beta cells in vivo.","evidence":"Co-IP, RIM mutagenesis, proteasome inhibitor, RB conditional knockout; conditional Pdx1 transgene with Neurog3-Cre lineage tracing","pmids":["21399612","21852533"],"confidence":"High","gaps":["Whether RB protection is direct or involves competition with SPOP not tested","Efficiency and completeness of alpha-to-beta conversion in adult animals unknown"]},{"year":2012,"claim":"The genome-wide direct target repertoire of PDX1 in primary islets was undefined; ChIP-seq in human and mouse islets revealed a conserved cistrome enriched for endocrine function, metabolic, and cell-survival genes.","evidence":"ChIP-seq in human and mouse islets with evolutionary conservation analysis","pmids":["22322596"],"confidence":"High","gaps":["Functional validation of most identified targets not performed","Condition-dependent (e.g. glucose-stimulated) binding changes not captured"]},{"year":2015,"claim":"PDX1's control of mitochondrial quality and pancreatic lineage specification was incompletely understood; PDX1 was shown to regulate mitophagy through transcriptional control of Clec16a–Nrdp1, to directly activate E-cadherin for epithelial morphogenesis, and to cooperate genome-wide with Sox9 to activate pancreatic and repress intestinal gene programs.","evidence":"ChIP-seq at Clec16a with adenoviral rescue and mitophagy assays; ChIP at E-cadherin promoter with Pdx1-/- embryo analysis; ChIP-seq for Pdx1 and Sox9 with conditional knockouts","pmids":["26085571","26657766","26440894"],"confidence":"High","gaps":["Whether Clec16a is rate-limiting for mitophagy in human islets unknown","Mechanism of Sox9–PDX1 cooperative binding not structurally defined"]},{"year":2018,"claim":"The structural basis for SPOP-mediated PDX1 degradation was unresolved; a crystal structure of the SPOP MATH domain bound to PDX1 residues 223–233 showed phosphorylation within the degron reduces SPOP binding, providing a mechanistic switch for PDX1 stability; concurrently, PDX1–ATF4/ATF5 complexes were found to co-occupy CARE motifs at stress/apoptosis genes.","evidence":"Crystal structure, ITC, NMR for SPOP–PDX1; co-IP, ChIP-seq, RNAseq, and Gpt2 knockout for ATF complexes","pmids":["30449689","30174228"],"confidence":"High","gaps":["Identity of kinase(s) that phosphorylate the SPOP degron in vivo unknown","Whether ATF4/ATF5 partnership is stress-specific or constitutive not fully resolved"]},{"year":2019,"claim":"The pathogenic kinase targeting PDX1 under glucotoxicity was unidentified; GSK3 was shown to phosphorylate PDX1 in diabetic islets, and GSK3 inhibition rescued GSIS in human islets; separately, iPSC-modeled transactivation domain mutations (P33T, C18R) confirmed structure–function requirements for PDX1 in human beta-cell differentiation.","evidence":"Phosphoproteomics of diabetic mouse islets, GSK3 inhibitor rescue in human islets; isogenic iPSC differentiation with ChIP-seq and RNA profiling","pmids":["30879985","30930126"],"confidence":"High","gaps":["Specific GSK3 phosphosites on PDX1 not all mapped","Whether GSK3 phosphorylation feeds into SPOP-dependent degradation not tested"]},{"year":2021,"claim":"How lipotoxicity disrupts PDX1 nuclear function was mechanistically undefined; palmitate was shown to trap PDX1 in cytoplasmic stress granules via PI3K/EIF2α-dependent disruption of nucleocytoplasmic transport, and disruption of stress granule assembly restored PDX1 nuclear localization and beta-cell function.","evidence":"Mass spectrometry of stress granule components, immunofluorescence, PI3K/EIF2α inhibitors, TIA1 knockout mice","pmids":["33569632"],"confidence":"High","gaps":["Whether stress granule trapping occurs with unsaturated fatty acids unknown","Direct RNA targets of PDX1 within stress granules not characterized"]},{"year":2024,"claim":"Whether PDX1 integrates circadian and inflammatory programs was unknown; PDX1 was found to silence NF-κB at circadian enhancers through long-range chromatin contacts involving SIN3A, and Bmal1 ablation disrupted genome-wide PDX1 binding, establishing PDX1 as a circadian-inflammatory gatekeeper in beta cells.","evidence":"Single-cell ATAC-seq, ChIP-seq, Hi-C, Pdx1 hypomorphic mice, Bmal1 beta-cell knockout, IL-1β receptor antagonism","pmids":["38171340"],"confidence":"High","gaps":["Whether circadian PDX1 binding dynamics are direct or Bmal1-dependent not fully separated","SIN3A recruitment mechanism to PDX1-bound sites not defined"]},{"year":null,"claim":"Key unresolved questions include: (1) the complete phosphorylation code integrating GSK3, CK2, JNK, and SPOP-degron phosphorylation into a unified PDX1 stability/localization model; (2) the structural basis for PDX1 cooperative interactions with its diverse cofactor partners; (3) which PDX1 chromatin targets are dynamically regulated by glucose versus constitutively bound; and (4) the mechanism by which homeodomain mutations impair transactivation despite preserved DNA occupancy.","evidence":"","pmids":[],"confidence":"Low","gaps":["No integrated phosphorylation map of PDX1","No full-length PDX1 structure available","Glucose-responsive versus constitutive target binding not systematically resolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,7,8,9,10,17,25,27,28]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,9,10,17,18,19,20,25,26,28,30,32,35]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,12,14,33]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14,33]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,9,10,17,25,27,30,32,35]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,24,27,28]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[11,19,31]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[15,21,30]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[21,26]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[12,23,29]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13,18,31]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[19,26,34]}],"complexes":[],"partners":["PBX1","PREP1","PAX6","NEUROD1","SETD7","SPOP","RB1","ATF4"],"other_free_text":[]},"mechanistic_narrative":"PDX1 is a homeodomain transcription factor that serves as a master regulator of pancreatic organogenesis, beta-cell identity, and glucose homeostasis. It binds cooperatively with cofactors including Pbx1–Prep1, Pax6, BETA2/E2A, and MafA to activate insulin, somatostatin, GLUT2, TFAM, Clec16a, and E-cadherin promoters, and recruits the H3K4 methyltransferase Set9 to convert RNA polymerase II from initiation to elongation mode at the insulin locus [PMID:8524276, PMID:10636926, PMID:16141209, PMID:26657766]. PDX1 nuclear availability is controlled by SUMO-1 modification, JNK-dependent nuclear export via a defined NES, sequestration in palmitate-induced stress granules, and phosphorylation by GSK3 and CK2, while the SPOP/PCIF1 E3 adaptor targets it for proteasomal degradation through a phosphorylation-sensitive degron whose crystal structure has been resolved [PMID:14633849, PMID:33569632, PMID:30879985, PMID:30449689]. Complete PDX1 loss causes pancreatic agenesis and haploinsufficiency leads to impaired beta-cell mass, ER stress susceptibility, defective mitophagy (via Clec16a–Nrdp1), reduced mitochondrial biogenesis (via TFAM), and circadian de-repression of NF-κB inflammatory programs, while gain-of-function drives acinar-to-ductal metaplasia through Stat3 [PMID:8631275, PMID:19855005, PMID:26085571, PMID:19656489, PMID:38171340, PMID:16751181]. Homozygous and compound heterozygous PDX1 mutations cause neonatal diabetes and pancreatic agenesis in humans [PMID:20009086, PMID:30930126]."},"prefetch_data":{"uniprot":{"accession":"P52945","full_name":"Pancreas/duodenum homeobox protein 1","aliases":["Glucose-sensitive factor","GSF","Insulin promoter factor 1","IPF-1","Insulin upstream factor 1","IUF-1","Islet/duodenum homeobox-1","IDX-1","Somatostatin-transactivating factor 1","STF-1"],"length_aa":283,"mass_kda":30.8,"function":"Activates insulin, somatostatin, glucokinase, islet amyloid polypeptide and glucose transporter type 2 gene transcription. Particularly involved in glucose-dependent regulation of insulin gene transcription. As part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Binds preferentially the DNA motif 5'-[CT]TAAT[TG]-3'. During development, specifies the early pancreatic epithelium, permitting its proliferation, branching and subsequent differentiation. At adult stage, required for maintaining the hormone-producing phenotype of the beta-cell","subcellular_location":"Nucleus; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/P52945/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDX1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDX1","total_profiled":1310},"omim":[{"mim_id":"621241","title":"PDX1-ASSOCIATED LONG NONCODING RNA, UPREGULATOR OF TRANSCRIPTION; PLUT","url":"https://www.omim.org/entry/621241"},{"mim_id":"619321","title":"GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF","url":"https://www.omim.org/entry/619321"},{"mim_id":"618500","title":"HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12","url":"https://www.omim.org/entry/618500"},{"mim_id":"616511","title":"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14","url":"https://www.omim.org/entry/616511"},{"mim_id":"610303","title":"MAF bZIP TRANSCRIPTION FACTOR A; MAFA","url":"https://www.omim.org/entry/610303"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":39.4},{"tissue":"pancreas","ntpm":12.2}],"url":"https://www.proteinatlas.org/search/PDX1"},"hgnc":{"alias_symbol":["IDX-1","STF-1","PDX-1","MODY4","GSF","IUF-1"],"prev_symbol":["IPF1"]},"alphafold":{"accession":"P52945","domains":[{"cath_id":"1.10.10.60","chopping":"155-205","consensus_level":"medium","plddt":98.0308,"start":155,"end":205}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P52945","model_url":"https://alphafold.ebi.ac.uk/files/AF-P52945-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P52945-F1-predicted_aligned_error_v6.png","plddt_mean":64.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDX1","jax_strain_url":"https://www.jax.org/strain/search?query=PDX1"},"sequence":{"accession":"P52945","fasta_url":"https://rest.uniprot.org/uniprotkb/P52945.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P52945/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P52945"}},"corpus_meta":[{"pmid":"8631275","id":"PMC_8631275","title":"PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8631275","citation_count":1292,"is_preprint":false},{"pmid":"9133560","id":"PMC_9133560","title":"A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice.","date":"1997","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9133560","citation_count":457,"is_preprint":false},{"pmid":"11781323","id":"PMC_11781323","title":"Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11781323","citation_count":332,"is_preprint":false},{"pmid":"12697734","id":"PMC_12697734","title":"Increased islet apoptosis in Pdx1+/- mice.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12697734","citation_count":294,"is_preprint":false},{"pmid":"10078550","id":"PMC_10078550","title":"The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration.","date":"1999","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10078550","citation_count":280,"is_preprint":false},{"pmid":"19855005","id":"PMC_19855005","title":"Pdx1 (MODY4) regulates pancreatic beta cell susceptibility to ER stress.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19855005","citation_count":188,"is_preprint":false},{"pmid":"14633849","id":"PMC_14633849","title":"Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/14633849","citation_count":183,"is_preprint":false},{"pmid":"15047618","id":"PMC_15047618","title":"Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15047618","citation_count":182,"is_preprint":false},{"pmid":"19817786","id":"PMC_19817786","title":"Pdx1 and other factors that regulate pancreatic beta-cell survival.","date":"2009","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19817786","citation_count":177,"is_preprint":false},{"pmid":"21852533","id":"PMC_21852533","title":"Context-specific α- to-β-cell reprogramming by forced Pdx1 expression.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/21852533","citation_count":165,"is_preprint":false},{"pmid":"11994408","id":"PMC_11994408","title":"Pdx1 restores beta cell function in Irs2 knockout mice.","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11994408","citation_count":154,"is_preprint":false},{"pmid":"8524276","id":"PMC_8524276","title":"The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8524276","citation_count":141,"is_preprint":false},{"pmid":"16751181","id":"PMC_16751181","title":"Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16751181","citation_count":136,"is_preprint":false},{"pmid":"17227548","id":"PMC_17227548","title":"PDX1 is essential for vitamin B6 biosynthesis, development and stress tolerance in Arabidopsis.","date":"2006","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17227548","citation_count":124,"is_preprint":false},{"pmid":"10331405","id":"PMC_10331405","title":"Sustained proliferation of PDX-1+ cells derived from human islets.","date":"1999","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/10331405","citation_count":119,"is_preprint":false},{"pmid":"9000703","id":"PMC_9000703","title":"Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy.","date":"1997","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9000703","citation_count":115,"is_preprint":false},{"pmid":"19654319","id":"PMC_19654319","title":"Autophagy regulates pancreatic beta cell death in response to Pdx1 deficiency and nutrient deprivation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19654319","citation_count":105,"is_preprint":false},{"pmid":"10636926","id":"PMC_10636926","title":"Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10636926","citation_count":105,"is_preprint":false},{"pmid":"19656489","id":"PMC_19656489","title":"PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression.","date":"2009","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19656489","citation_count":103,"is_preprint":false},{"pmid":"17226789","id":"PMC_17226789","title":"Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17226789","citation_count":102,"is_preprint":false},{"pmid":"14550306","id":"PMC_14550306","title":"Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14550306","citation_count":98,"is_preprint":false},{"pmid":"9111329","id":"PMC_9111329","title":"Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9111329","citation_count":97,"is_preprint":false},{"pmid":"15028942","id":"PMC_15028942","title":"PDX-1 and the pancreas.","date":"2004","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/15028942","citation_count":90,"is_preprint":false},{"pmid":"30879985","id":"PMC_30879985","title":"Phosphoproteomics Reveals the GSK3-PDX1 Axis as a Key Pathogenic Signaling Node in Diabetic Islets.","date":"2019","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30879985","citation_count":88,"is_preprint":false},{"pmid":"9933599","id":"PMC_9933599","title":"Functional and cooperative interactions between the homeodomain PDX1, Pbx, and Prep1 factors on the somatostatin promoter.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9933599","citation_count":86,"is_preprint":false},{"pmid":"36589234","id":"PMC_36589234","title":"PDX1 is the cornerstone of pancreatic β-cell functions and identity.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36589234","citation_count":85,"is_preprint":false},{"pmid":"12488243","id":"PMC_12488243","title":"Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation.","date":"2002","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12488243","citation_count":85,"is_preprint":false},{"pmid":"17659992","id":"PMC_17659992","title":"A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis.","date":"2007","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17659992","citation_count":85,"is_preprint":false},{"pmid":"17235302","id":"PMC_17235302","title":"Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver.","date":"2007","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/17235302","citation_count":84,"is_preprint":false},{"pmid":"17761679","id":"PMC_17761679","title":"Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17761679","citation_count":84,"is_preprint":false},{"pmid":"8567692","id":"PMC_8567692","title":"Pancreatic islet expression of the homeobox factor STF-1 relies on an E-box motif that binds USF.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8567692","citation_count":81,"is_preprint":false},{"pmid":"15862113","id":"PMC_15862113","title":"Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15862113","citation_count":81,"is_preprint":false},{"pmid":"9199333","id":"PMC_9199333","title":"Functional characterization of the transactivation properties of the PDX-1 homeodomain protein.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9199333","citation_count":81,"is_preprint":false},{"pmid":"28087712","id":"PMC_28087712","title":"PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/28087712","citation_count":79,"is_preprint":false},{"pmid":"8954967","id":"PMC_8954967","title":"Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8954967","citation_count":79,"is_preprint":false},{"pmid":"20009086","id":"PMC_20009086","title":"A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency.","date":"2009","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/20009086","citation_count":79,"is_preprint":false},{"pmid":"29396371","id":"PMC_29396371","title":"Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.","date":"2018","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/29396371","citation_count":73,"is_preprint":false},{"pmid":"16141209","id":"PMC_16141209","title":"Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16141209","citation_count":73,"is_preprint":false},{"pmid":"26085571","id":"PMC_26085571","title":"Diabetes Susceptibility Genes Pdx1 and Clec16a Function in a Pathway Regulating Mitophagy in β-Cells.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26085571","citation_count":71,"is_preprint":false},{"pmid":"12947327","id":"PMC_12947327","title":"Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer.","date":"2003","source":"Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/12947327","citation_count":70,"is_preprint":false},{"pmid":"11457885","id":"PMC_11457885","title":"Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1.","date":"2001","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11457885","citation_count":70,"is_preprint":false},{"pmid":"30930126","id":"PMC_30930126","title":"Point mutations in the PDX1 transactivation domain impair human β-cell development and function.","date":"2019","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30930126","citation_count":68,"is_preprint":false},{"pmid":"28580283","id":"PMC_28580283","title":"Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells.","date":"2017","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28580283","citation_count":67,"is_preprint":false},{"pmid":"19095744","id":"PMC_19095744","title":"Maturation of adult beta-cells revealed using a Pdx1/insulin dual-reporter lentivirus.","date":"2008","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19095744","citation_count":66,"is_preprint":false},{"pmid":"26440894","id":"PMC_26440894","title":"A Gene Regulatory Network Cooperatively Controlled by Pdx1 and Sox9 Governs Lineage Allocation of Foregut Progenitor Cells.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26440894","citation_count":64,"is_preprint":false},{"pmid":"14701942","id":"PMC_14701942","title":"Conserved transcriptional regulatory domains of the pdx-1 gene.","date":"2003","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/14701942","citation_count":63,"is_preprint":false},{"pmid":"11473041","id":"PMC_11473041","title":"IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal With type 2 diabetes.","date":"2001","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11473041","citation_count":60,"is_preprint":false},{"pmid":"33514698","id":"PMC_33514698","title":"PDX1LOW MAFALOW β-cells contribute to islet function and insulin release.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33514698","citation_count":59,"is_preprint":false},{"pmid":"15582592","id":"PMC_15582592","title":"Constitutively active PDX1 induced efficient insulin production in adult murine liver.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15582592","citation_count":59,"is_preprint":false},{"pmid":"15896300","id":"PMC_15896300","title":"Mechanism of PDX-1 protein transduction.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15896300","citation_count":57,"is_preprint":false},{"pmid":"16092045","id":"PMC_16092045","title":"IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.","date":"2005","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/16092045","citation_count":55,"is_preprint":false},{"pmid":"22322596","id":"PMC_22322596","title":"Research resource: the pdx1 cistrome of pancreatic islets.","date":"2012","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/22322596","citation_count":54,"is_preprint":false},{"pmid":"10429201","id":"PMC_10429201","title":"The nuclear localization signal (NLS) of PDX-1 is part of the homeodomain and represents a novel type of NLS.","date":"1999","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10429201","citation_count":53,"is_preprint":false},{"pmid":"15121856","id":"PMC_15121856","title":"Identification of PCIF1, a POZ domain protein that inhibits PDX-1 (MODY4) transcriptional activity.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15121856","citation_count":53,"is_preprint":false},{"pmid":"28705881","id":"PMC_28705881","title":"Defining a Novel Role for the Pdx1 Transcription Factor in Islet β-Cell Maturation and Proliferation During Weaning.","date":"2017","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/28705881","citation_count":52,"is_preprint":false},{"pmid":"11270685","id":"PMC_11270685","title":"Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.","date":"2001","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/11270685","citation_count":50,"is_preprint":false},{"pmid":"32243891","id":"PMC_32243891","title":"LncRNA MALAT1 induces the dysfunction of β cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes.","date":"2020","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32243891","citation_count":49,"is_preprint":false},{"pmid":"21297446","id":"PMC_21297446","title":"Pdx1 expression in pancreatic precursor lesions and neoplasms.","date":"2011","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/21297446","citation_count":48,"is_preprint":false},{"pmid":"36551213","id":"PMC_36551213","title":"PDX-1: A Promising Therapeutic Target to Reverse Diabetes.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36551213","citation_count":44,"is_preprint":false},{"pmid":"10094480","id":"PMC_10094480","title":"Pax6 and Pdx1 form a functional complex on the rat somatostatin gene upstream enhancer.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10094480","citation_count":44,"is_preprint":false},{"pmid":"9679043","id":"PMC_9679043","title":"Misexpression of the pancreatic homeodomain protein IDX-1 by the Hoxa-4 promoter associated with agenesis of the cecum.","date":"1998","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/9679043","citation_count":42,"is_preprint":false},{"pmid":"25628604","id":"PMC_25628604","title":"Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta Cells.","date":"2015","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25628604","citation_count":42,"is_preprint":false},{"pmid":"21108535","id":"PMC_21108535","title":"NKX6.1 promotes PDX-1-induced liver to pancreatic β-cells reprogramming.","date":"2010","source":"Cellular reprogramming","url":"https://pubmed.ncbi.nlm.nih.gov/21108535","citation_count":41,"is_preprint":false},{"pmid":"19793922","id":"PMC_19793922","title":"Pancreatic ductal morphogenesis and the Pdx1 homeodomain transcription factor.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19793922","citation_count":41,"is_preprint":false},{"pmid":"22034951","id":"PMC_22034951","title":"Requirement for Pdx1 in specification of latent endocrine progenitors in zebrafish.","date":"2011","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/22034951","citation_count":41,"is_preprint":false},{"pmid":"19689288","id":"PMC_19689288","title":"Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells.","date":"2009","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19689288","citation_count":39,"is_preprint":false},{"pmid":"9399911","id":"PMC_9399911","title":"Mutations in PDX1, the human lipoyl-containing component X of the pyruvate dehydrogenase-complex gene on chromosome 11p1, in congenital lactic acidosis.","date":"1997","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9399911","citation_count":39,"is_preprint":false},{"pmid":"17449132","id":"PMC_17449132","title":"Role of PDX-1 and MafA as a potential therapeutic target for diabetes.","date":"2007","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/17449132","citation_count":38,"is_preprint":false},{"pmid":"24505140","id":"PMC_24505140","title":"The pseudoenzyme PDX1.2 boosts vitamin B6 biosynthesis under heat and oxidative stress in Arabidopsis.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24505140","citation_count":38,"is_preprint":false},{"pmid":"20339896","id":"PMC_20339896","title":"CK2 phosphorylation of Pdx-1 regulates its transcription factor activity.","date":"2010","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20339896","citation_count":38,"is_preprint":false},{"pmid":"21490060","id":"PMC_21490060","title":"The Cdk4-E2f1 pathway regulates early pancreas development by targeting Pdx1+ progenitors and Ngn3+ endocrine precursors.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21490060","citation_count":37,"is_preprint":false},{"pmid":"11117522","id":"PMC_11117522","title":"The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.","date":"2000","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11117522","citation_count":35,"is_preprint":false},{"pmid":"27615141","id":"PMC_27615141","title":"Impact of Pdx1-associated chromatin modifiers on islet β-cells.","date":"2016","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27615141","citation_count":34,"is_preprint":false},{"pmid":"24312421","id":"PMC_24312421","title":"Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312421","citation_count":34,"is_preprint":false},{"pmid":"22028850","id":"PMC_22028850","title":"Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22028850","citation_count":33,"is_preprint":false},{"pmid":"15028719","id":"PMC_15028719","title":"Identification of a novel PDX-1 binding site in the human insulin gene enhancer.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15028719","citation_count":33,"is_preprint":false},{"pmid":"33564250","id":"PMC_33564250","title":"Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus.","date":"2021","source":"Diabetes, metabolic syndrome and obesity : targets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33564250","citation_count":32,"is_preprint":false},{"pmid":"36187092","id":"PMC_36187092","title":"Regulation of Pdx1 by oxidative stress and Nrf2 in pancreatic beta-cells.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36187092","citation_count":31,"is_preprint":false},{"pmid":"16461554","id":"PMC_16461554","title":"Involvement of PDX-1 in activation of human insulin gene transcription.","date":"2006","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16461554","citation_count":31,"is_preprint":false},{"pmid":"24290880","id":"PMC_24290880","title":"A small-molecule inducer of PDX1 expression identified by high-throughput screening.","date":"2013","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/24290880","citation_count":31,"is_preprint":false},{"pmid":"32139597","id":"PMC_32139597","title":"Activation of Retinal Angiogenesis in Hyperglycemic pdx1  Zebrafish Mutants.","date":"2020","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/32139597","citation_count":31,"is_preprint":false},{"pmid":"30428031","id":"PMC_30428031","title":"Zebrafish hhex-null mutant develops an intrahepatic intestinal tube due to de-repression of cdx1b and pdx1.","date":"2019","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30428031","citation_count":31,"is_preprint":false},{"pmid":"12389618","id":"PMC_12389618","title":"Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation.","date":"2002","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/12389618","citation_count":30,"is_preprint":false},{"pmid":"18477649","id":"PMC_18477649","title":"Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer.","date":"2008","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/18477649","citation_count":30,"is_preprint":false},{"pmid":"26657766","id":"PMC_26657766","title":"Pdx1 regulates pancreas tubulogenesis and E-cadherin expression.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26657766","citation_count":28,"is_preprint":false},{"pmid":"31887289","id":"PMC_31887289","title":"Andrographolide promotes pancreatic duct cells differentiation into insulin-producing cells by targeting PDX-1.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31887289","citation_count":28,"is_preprint":false},{"pmid":"9312185","id":"PMC_9312185","title":"Suppression of transcription factor PDX-1/IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells.","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9312185","citation_count":28,"is_preprint":false},{"pmid":"32166879","id":"PMC_32166879","title":"Generation of viable PDX1 gene-edited founder pigs as providers of nonmosaics.","date":"2020","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/32166879","citation_count":27,"is_preprint":false},{"pmid":"30353648","id":"PMC_30353648","title":"Liraglutide protects against glucolipotoxicity-induced RIN-m5F β-cell apoptosis through restoration of PDX1 expression.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30353648","citation_count":27,"is_preprint":false},{"pmid":"28017717","id":"PMC_28017717","title":"Preserving expression of Pdx1 improves β-cell failure in diabetic mice.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28017717","citation_count":26,"is_preprint":false},{"pmid":"30174228","id":"PMC_30174228","title":"A PDX1-ATF transcriptional complex governs β cell survival during stress.","date":"2018","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30174228","citation_count":26,"is_preprint":false},{"pmid":"21399612","id":"PMC_21399612","title":"RB regulates pancreas development by stabilizing Pdx1.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21399612","citation_count":25,"is_preprint":false},{"pmid":"34462257","id":"PMC_34462257","title":"OGT Regulates Mitochondrial Biogenesis and Function via Diabetes Susceptibility Gene Pdx1.","date":"2021","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/34462257","citation_count":24,"is_preprint":false},{"pmid":"38171340","id":"PMC_38171340","title":"Repression of latent NF-κB enhancers by PDX1 regulates β cell functional heterogeneity.","date":"2024","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38171340","citation_count":24,"is_preprint":false},{"pmid":"33569632","id":"PMC_33569632","title":"Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function.","date":"2021","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/33569632","citation_count":24,"is_preprint":false},{"pmid":"30449689","id":"PMC_30449689","title":"The Structure of the SPOP-Pdx1 Interface Reveals Insights into the Phosphorylation-Dependent Binding Regulation.","date":"2018","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/30449689","citation_count":24,"is_preprint":false},{"pmid":"18036209","id":"PMC_18036209","title":"Gene array identification of Ipf1/Pdx1-/- regulated genes in pancreatic progenitor cells.","date":"2007","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18036209","citation_count":24,"is_preprint":false},{"pmid":"34988346","id":"PMC_34988346","title":"First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications.","date":"2021","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/34988346","citation_count":23,"is_preprint":false},{"pmid":"15094056","id":"PMC_15094056","title":"Functional complementation between the PDX1 vitamin B6 biosynthetic gene of Cercospora nicotianae and pdxJ of Escherichia coli.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15094056","citation_count":23,"is_preprint":false},{"pmid":"15037986","id":"PMC_15037986","title":"The role of pdx1 and HNF6 in proliferation and differentiation of endocrine precursors.","date":"2004","source":"Diabetes/metabolism research and reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15037986","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47908,"output_tokens":8266,"usd":0.133857},"stage2":{"model":"claude-opus-4-6","input_tokens":12104,"output_tokens":5528,"usd":0.29808},"total_usd":0.431937,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"PDX-1 (mouse pdx-1) is required for pancreatic outgrowth and differentiation; null mutation leads to apancreatic mice with only limited dorsal bud outgrowth lacking insulin/amylase-positive cells, demonstrating PDX-1 is essential for pancreatic progenitor proliferation and differentiation.\",\n      \"method\": \"Gene targeting (knockout mouse), histology, immunostaining, lacZ reporter fusion\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — constitutive knockout with rigorous developmental phenotyping, replicated across two independent null alleles\",\n      \"pmids\": [\"8631275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PDX-1/STF-1 binds cooperatively with the homeodomain cofactor Pbx to regulatory elements in the somatostatin promoter; cooperative binding requires both the conserved N-terminal FPWMK pentapeptide motif and the N-terminal arm of the PDX-1 homeodomain.\",\n      \"method\": \"In vitro DNA-binding assays, co-immunoprecipitation, mutational analysis of FPWMK motif and homeodomain\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted cooperative DNA binding in vitro with domain mutagenesis\",\n      \"pmids\": [\"8524276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PDX-1 transactivation is mediated by three conserved N-terminal subdomains (amino acids 13-22, 32-38, 60-73); these same sequences are required for synergistic activation of insulin gene transcription with E2A-encoded bHLH proteins.\",\n      \"method\": \"GAL4-chimera transactivation assays, deletion/point mutagenesis, stable expression in betaTC3 cells\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed mutagenesis with multiple functional readouts in beta-cell lines\",\n      \"pmids\": [\"9199333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PDX-1/STF-1 gene expression in pancreatic islets requires an E-box element at -104 bp recognized by the helix-loop-helix/leucine zipper factor USF; point mutations disrupting USF binding impair STF-1 promoter activity in transgenic mice.\",\n      \"method\": \"Transgenic reporter mice, site-directed mutagenesis, EMSA\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — transgenic reporter + mutagenesis with in vivo validation\",\n      \"pmids\": [\"8567692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PDX-1 (IDX-1) protein is markedly reduced (~80%) in islets from partially pancreatectomized hyperglycemic rats, coinciding with reduced GLUT2 and insulin mRNAs, suggesting PDX-1 loss mediates transcriptional dysfunction during chronic hyperglycemia.\",\n      \"method\": \"Western blot, quantitative RT-PCR, immunofluorescence on isolated islets\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical methods in a defined in vivo model; single lab, correlational\",\n      \"pmids\": [\"9000703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"HNF-3β activates and glucocorticoids repress PDX-1/STF-1 gene expression through a composite islet-specific enhancer; overexpression of HNF-3β suppresses glucocorticoid receptor-mediated inhibition of PDX-1 transcription.\",\n      \"method\": \"Transfection reporter assays, EMSA, overexpression in islet cell lines\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional dissection with multiple regulatory elements; single lab\",\n      \"pmids\": [\"9111329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PDX-1 bears a nuclear localization signal (NLS) that resides within helix 3 of the homeodomain; point mutations of basic residues in helix 3 abolish nuclear transport, identifying a novel class of NLS.\",\n      \"method\": \"EGFP-tagged deletion/point mutant constructs expressed in COS-7 cells, fluorescence microscopy, Western blot\",\n      \"journal\": \"European Journal of Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with direct subcellular localization readout\",\n      \"pmids\": [\"10429201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PDX1 and Pbx-Prep1 heterodimeric complex cooperatively activate the somatostatin mini-enhancer; Pbx1 and Prep1 bind cooperatively to the UE-A element and require co-expression of PDX1 binding to the adjacent TSEI element for strong transcriptional activation.\",\n      \"method\": \"EMSA with recombinant proteins, transient transfection reporter assays\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted cooperative DNA binding with recombinant proteins plus functional reporter assays\",\n      \"pmids\": [\"9933599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pax6 and PDX1 form a functional complex on the somatostatin upstream enhancer; PDX1 potentiates Pax6-mediated activation, and simultaneous binding of PDX1 to the B-element and Pax6 to the C-element is required for beta/delta-cell-specific activity.\",\n      \"method\": \"EMSA, transient transfection reporter assays, site-directed mutagenesis\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA binding + functional reporter with mutagenesis; single lab\",\n      \"pmids\": [\"10094480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PDX-1, BETA2/NeuroD, and E2A co-expressed in non-beta cells synergistically activate the insulin promoter ~160-fold; PDX-1 alone produces only modest activation, demonstrating that high-level insulin transcription requires cooperative interaction of all three factors.\",\n      \"method\": \"Transfection of non-beta cells with combinations of transcription factors, reporter gene assays\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic combinatorial overexpression with defined promoter readout\",\n      \"pmids\": [\"10636926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The PDX-1 transactivation domain confers beta-cell-specific and glucose-responsive activation of the insulin gene through cooperative interactions with other enhancer-bound factors (E1 element activators); heterologous activation domains (VP16, E1A) cannot substitute functionally.\",\n      \"method\": \"GAL4-substituted insulin enhancer reporter assays in beta-cell and non-beta-cell lines, mutagenesis\",\n      \"journal\": \"Molecular Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed structure-function analysis with multiple chimeras and mutants\",\n      \"pmids\": [\"11117522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Haploinsufficiency for PDX-1 impairs glucose-stimulated insulin secretion in mice by reducing PDX-1 and GLUT2 expression, diminishing NAD(P)H generation (~30%), and impairing mitochondrial function and intracellular Ca2+ mobilization in beta cells.\",\n      \"method\": \"PDX-1+/- mice, perfused pancreas secretion assays, NAD(P)H imaging, Western blot, glucose tolerance testing\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal physiological and biochemical methods in a defined genetic model\",\n      \"pmids\": [\"11781323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PDX-1 is modified by SUMO-1 in beta cells; this sumoylation contributes to the molecular mass shift from 31 to 46 kDa, promotes nuclear localization and stability of PDX-1, and is required for full insulin gene transcriptional activity.\",\n      \"method\": \"Transfection, co-immunoprecipitation, RNA interference against SUMO-1, proteasome inhibitor treatment, reporter assays\",\n      \"journal\": \"American Journal of Physiology - Endocrinology and Metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods including RNAi and pharmacological inhibition; single lab\",\n      \"pmids\": [\"12488243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Transgenic expression of Pdx1 rescues beta cell mass and function and prevents diabetes in Irs2-/- mice, demonstrating that Pdx1 acts downstream of IRS2 signaling to maintain beta cell mass; Pdx1 haploinsufficiency accelerates diabetes onset in Irs2-/- mice.\",\n      \"method\": \"Genetic epistasis (Irs2-/- x Pdx1 transgenic and Pdx1+/- mice), glucose tolerance, histology\",\n      \"journal\": \"The Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic epistasis with multiple intersecting alleles and defined functional readouts\",\n      \"pmids\": [\"11994408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PDX-1 is translocated from nucleus to cytoplasm in response to oxidative stress via a JNK-dependent mechanism; a nuclear export signal (NES) was identified at amino acids 82-94 of mouse PDX-1 that overrides the NLS, and this translocation is blocked by leptomycin B or dominant-negative JNK.\",\n      \"method\": \"Live-cell imaging of GFP-PDX-1, dominant-negative JNK expression, leptomycin B treatment, NES identification by deletion mapping in HIT-T15 cells\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic identification of NES, live imaging, pharmacological and genetic dissection of JNK pathway\",\n      \"pmids\": [\"14633849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Increased Pdx1+/- beta cell apoptosis (with reduced Bcl-XL and Bcl-2), abnormal islet architecture, and failure of beta cell mass expansion with age underlie the organ-level insulin secretion defect in Pdx1 heterozygous mice.\",\n      \"method\": \"TUNEL, active caspase-3 staining, Ca2+ imaging, single-cell patch-clamp, Western blot for Bcl-XL/Bcl-2 in Pdx1+/- islets\",\n      \"journal\": \"The Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (TUNEL, caspase-3, electrophysiology, Western blot) in a defined genetic model\",\n      \"pmids\": [\"12697734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PCIF1/SPOP, a POZ domain protein, interacts with the C-terminus of PDX-1 both in vitro and in vivo; coexpression of PCIF1 alters subnuclear distribution of PDX-1 and inhibits PDX-1 transactivation of target gene promoters in a C-terminus-dependent manner.\",\n      \"method\": \"Yeast two-hybrid (identification), co-immunoprecipitation, reporter assays, overexpression in MIN6 cells\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding demonstrated plus functional reporter assays; single lab\",\n      \"pmids\": [\"15121856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pdx-1 links histone H3-Lys-4 dimethylation to RNA polymerase II elongation at the insulin gene; Pdx-1 directly interacts with the methyltransferase Set9 (co-IP), recruits Set9 to the insulin promoter, and Pdx-1 knockdown reduces H3-Lys-4 dimethylation and shifts pol II from elongation to initiation isoform at the insulin locus.\",\n      \"method\": \"siRNA knockdown, chromatin immunoprecipitation (ChIP), co-immunoprecipitation (Pdx-1 and Set9), immunohistochemistry\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct interaction by co-IP plus ChIP-based mechanistic dissection with siRNA\",\n      \"pmids\": [\"16141209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Persistent/constitutive PDX-1 expression in all pancreatic lineages causes acinar-to-ductal metaplasia through cell-autonomous activation of Stat3; genetic ablation of Stat3 in the transgenic pancreas profoundly suppresses the metaplastic phenotype.\",\n      \"method\": \"Transgenic overexpression (CAG-PDX1), genetic Stat3 knockout epistasis, histology\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with clean phenotypic rescue; replicated in vivo\",\n      \"pmids\": [\"16751181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PDX-1 identifies and directly activates the TFAM (mitochondrial transcription factor A) gene in beta cells; PDX-1 deficiency reduces TFAM expression, decreases mtDNA copy number and respiratory chain activity, and impairs ATP synthesis and glucose-stimulated insulin secretion; adenoviral TFAM restoration rescues these defects.\",\n      \"method\": \"Dominant-negative Pdx1 adenovirus, transcript profiling, ChIP (PDX-1 occupancy at TFAM), adenoviral TFAM rescue in rat islets, mtDNA measurement\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP demonstrating direct occupancy of TFAM promoter, gene rescue by adenoviral TFAM, multiple orthogonal methods\",\n      \"pmids\": [\"19656489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pdx1 regulates beta cell susceptibility to ER stress; Pdx1-deficient beta cells show ER stress markers and enhanced ER stress-associated apoptosis; chromatin occupancy and expression microarray analysis reveal that Pdx1 directly regulates a broad set of ER function genes including those involved in disulfide bond formation, protein folding, and the unfolded protein response.\",\n      \"method\": \"High-fat diet Pdx1+/- model, Min6 siRNA knockdown, chromatin occupancy ChIP, expression microarray, ER stress markers\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP + microarray + defined genetic model with multiple orthogonal methods\",\n      \"pmids\": [\"19855005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Increased autophagy contributes to Pdx1-deficiency-induced beta cell death; inhibition of autophagy (pharmacological or Becn1 haploinsufficiency) prolongs survival of Pdx1-deficient MIN6 cells and improves glucose tolerance and beta cell mass in Pdx1+/- mice on high-fat diet.\",\n      \"method\": \"Lentiviral shRNA knockdown of Pdx1 in MIN6, autophagy inhibitors, Pdx1+/- x Becn1+/- genetic cross, metabolic testing\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis and pharmacological rescue; single lab\",\n      \"pmids\": [\"19654319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Protein kinase CK2 phosphorylates Pdx-1 at Thr231 and Ser232, and this phosphorylation regulates the transcriptional activity of Pdx-1 at the insulin promoter; inhibition of CK2 elevates insulin release from pancreatic beta cells.\",\n      \"method\": \"In vitro kinase assay with Pdx-1 fragments, phosphorylation site mutagenesis, insulin promoter reporter assays, CK2 inhibitor treatment\",\n      \"journal\": \"Cellular and Molecular Life Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with mutagenesis plus functional reporter; single lab\",\n      \"pmids\": [\"20339896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The retinoblastoma protein RB associates with and stabilizes Pdx-1 through a conserved RB-interaction motif (RIM) in Pdx-1; point mutations in the RIM reduce RB-Pdx-1 complex formation and promote proteasomal degradation of Pdx-1; RB occupies promoters of beta-cell-specific genes and RB deficiency reduces Pdx-1 expression and pancreas size in vivo.\",\n      \"method\": \"Co-immunoprecipitation, point mutagenesis of RIM, proteasome inhibitor experiments, ChIP, RB conditional knockout mice\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding by co-IP, mutagenesis of interaction motif, in vivo genetic validation\",\n      \"pmids\": [\"21399612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Forced Pdx1 expression from the Neurogenin-3 stage onward causes postnatal conversion of alpha cells (glucagon/Arx-positive) through a glucagon-insulin double-positive intermediate to cells indistinguishable from normal beta cells; this context-dependent reprogramming requires Pdx1 activity in Neurog3+ cells but not in mature glucagon-expressing cells.\",\n      \"method\": \"Conditional Pdx1 transgene (Neurog3-Cre driver), lineage tracing, immunostaining, genetic epistasis\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional genetic approach with lineage tracing; clean phenotypic characterization\",\n      \"pmids\": [\"21852533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Genome-wide ChIP-seq of Pdx1 in human and mouse islets identifies a conserved cistrome enriched for genes involved in endocrine function, metabolic disorders, signaling pathways, and cell survival, defining the direct transcriptional targets mediating Pdx1's role in islet function.\",\n      \"method\": \"ChIP-seq in human and mouse islets, evolutionary conservation analysis\",\n      \"journal\": \"Molecular Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genome-wide chromatin occupancy in primary tissue from two species\",\n      \"pmids\": [\"22322596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pdx1 regulates mitophagy in pancreatic beta cells through transcriptional control of Clec16a and its downstream target Nrdp1 (E3 ubiquitin ligase); loss of Pdx1 impairs autophagosome-lysosome fusion during mitophagy, and restoration of Clec16a rescues mitochondrial trafficking, respiration, and glucose-stimulated insulin secretion.\",\n      \"method\": \"ChIP-seq (Pdx1 occupancy at Clec16a), expression microarray, adenoviral Clec16a rescue, mitophagy flux assays, Pdx1+/- islets\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP-seq plus adenoviral rescue of downstream pathway with functional mitophagy readout\",\n      \"pmids\": [\"26085571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pdx1 and Sox9 cooperatively bind regulatory sequences near pancreatic and intestinal differentiation genes, jointly activating pancreatic lineage genes and repressing the intestinal lineage; genetic studies show dual and cooperative roles for both factors in pancreatic lineage induction.\",\n      \"method\": \"ChIP-seq (Pdx1 and Sox9 occupancy), genetic epistasis with conditional knockouts, gene expression analysis\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genome-wide ChIP-seq plus genetic epistasis in vivo\",\n      \"pmids\": [\"26440894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pdx1 directly binds and activates the E-cadherin (Cdh1) promoter via two conserved binding sites; Pdx1 is required in vivo for maintenance of E-cadherin expression, actomyosin complex activity, and epithelial cell shape during pancreatic tubulogenesis.\",\n      \"method\": \"ChIP (Pdx1 at E-cad promoter), reporter assays, Pdx1-/- mouse embryo analysis, immunostaining\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct ChIP plus reporter assays plus in vivo genetic phenotyping\",\n      \"pmids\": [\"26657766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SPOP (PCIF1) binds directly to Pdx1 residues 223-233 with low micromolar affinity via its MATH domain; the SPOP-Pdx1 crystal structure shows an extended interface; phosphorylation of Pdx1 within this region reduces its affinity for SPOP, providing a regulatory mechanism controlling Pdx1 ubiquitination and proteasomal degradation.\",\n      \"method\": \"Crystal structure of SPOP-Pdx1 complex, isothermal titration calorimetry (ITC), NMR spectroscopy\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with ITC and NMR validation of phosphorylation-dependent binding\",\n      \"pmids\": [\"30449689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PDX1 forms stress-inducible complexes with ATF4 and ATF5 in beta cells; these complexes co-occupy composite C/EBP-ATF (CARE) motifs at stress and apoptosis genes (including Gpt2, Chac1, Slc7a1); PDX1-ATF complex governs beta cell survival, and deficiency of Gpt2 reduces stress-induced apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, RNAseq (shRNA knockdown of Pdx1, Atf4, Atf5), caspase-3 activation assay\",\n      \"journal\": \"Molecular Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — co-IP, ChIP-seq, and RNAseq with downstream gene knockout validation\",\n      \"pmids\": [\"30174228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GSK3 kinase phosphorylates Pdx1 in diabetic islets; pharmacological GSK3 inhibition rescues glucose-stimulated insulin secretion in human islets under glucotoxicity, identifying GSK3-PDX1 as a key pathogenic signaling axis.\",\n      \"method\": \"Mass spectrometry-based phosphoproteomics of diabetic mouse islets, GSK3 inhibitor treatment of human islets, GSIS assays\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative phosphoproteomics plus pharmacological rescue with functional readout; replicated in human islets\",\n      \"pmids\": [\"30879985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Point mutations in the PDX1 transactivation domain (P33T, C18R) impair beta-cell differentiation and function; iPSC modeling shows these mutations reduce expression of PDX1-bound target genes including MNX1, PDX1 itself (autoregulation), and MEG3/NNAT in pancreatic progenitors.\",\n      \"method\": \"iPSC lines with engineered mutations, beta-cell differentiation protocol, ChIP-seq (PDX1 occupancy), RNA expression profiling\",\n      \"journal\": \"Molecular Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — isogenic iPSC models with ChIP-seq and transcriptomics; human disease mutations validated\",\n      \"pmids\": [\"30930126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Saturated fatty acids (palmitic acid) trap PDX1 in cytoplasmic stress granules in beta cells by disrupting nucleocytoplasmic transport via a PI3K/EIF2α-dependent mechanism; PDX1 was identified as a stress granule component by mass spectrometry; disruption of stress granule assembly (PI3K/EIF2α inhibitors or TIA1 deletion) restores PDX1 nuclear localization and ameliorates beta cell dysfunction.\",\n      \"method\": \"Mass spectrometry of stress granule components, immunofluorescence, nucleocytoplasmic transport reporters, PI3K/EIF2α inhibitors, TIA1 knockout mice\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — MS identification plus genetic deletion plus pharmacological rescue with functional readout\",\n      \"pmids\": [\"33569632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"OGT (O-GlcNAc transferase) regulates beta cell mitochondrial morphology and bioenergetics partly through Pdx1; constitutive OGT deletion reduces Pdx1 levels, and overexpression of Pdx1 in OGT-deficient islets rescues mitochondrial morphology, insulin content, and mitochondrial function.\",\n      \"method\": \"Conditional OGT knockout mice, islet proteomics, adenoviral Pdx1 overexpression rescue, oxygen consumption rate assay\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with adenoviral rescue, but OGT-Pdx1 direct biochemical link not shown\",\n      \"pmids\": [\"34462257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PDX1 silences NF-κB at circadian and inflammatory enhancers in beta cells through long-range chromatin contacts involving SIN3A; PDX1 hypomorphic mice show de-repression of NF-κB and impaired nocturnal glucose tolerance; Bmal1 ablation disrupts genome-wide PDX1 and NF-κB DNA binding, and antagonizing the IL-1β receptor (NF-κB target) improves insulin secretion in Pdx1 hypomorphic islets.\",\n      \"method\": \"Single-cell ATAC-seq atlas of human islets, ChIP-seq, 3D chromatin analysis (Hi-C/proximity ligation), Pdx1 hypomorphic mice, Bmal1 beta-cell knockout, pharmacological IL-1β receptor antagonism\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP-seq, 3D chromatin structure, single-cell epigenomics, and genetic + pharmacological rescue\",\n      \"pmids\": [\"38171340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"E178G substitution in the PDX1 homeodomain causes neonatal diabetes by reducing Pdx1 transactivation activity despite normal nuclear localization, expression level, and chromatin occupancy, demonstrating that homeodomain integrity is required for transcriptional activation independently of DNA binding.\",\n      \"method\": \"Genetic analysis of consanguineous family, recombinant protein functional assays (transcriptional activation, nuclear localization, chromatin occupancy) in cell lines\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical functional assays with disease mutation; single lab\",\n      \"pmids\": [\"20009086\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDX1 is a homeodomain transcription factor that acts as a master regulator of pancreatic development and adult beta-cell function: it binds insulin, somatostatin, IAPP, GLUT2, glucokinase, TFAM, E-cadherin, Clec16a, and other target gene promoters (directly demonstrated by ChIP), recruits coactivators including the H3K4 methyltransferase Set9 to drive RNA pol II elongation, forms cooperative complexes with Pbx, Prep1, Pax6, BETA2/E2A, MafA, HMGA1, ATF4/ATF5 and is stabilized by RB interaction; its nuclear localization is regulated by SUMO-1 modification, JNK-dependent nuclear export via a defined NES, trapping in stress granules by saturated fatty acids, and GSK3/CK2 phosphorylation; SPOP/PCIF1 targets PDX1 for proteasomal degradation via a phosphorylation-sensitive MATH-domain interaction; complete PDX1 loss causes pancreatic agenesis, haploinsufficiency impairs beta-cell mass, ER function, mitophagy (via Clec16a-Nrdp1), and mitochondrial biogenesis (via TFAM), and high PDX1 induces acinar-to-ductal metaplasia through Stat3 activation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PDX1 is a homeodomain transcription factor that serves as a master regulator of pancreatic organogenesis, beta-cell identity, and glucose homeostasis. It binds cooperatively with cofactors including Pbx1–Prep1, Pax6, BETA2/E2A, and MafA to activate insulin, somatostatin, GLUT2, TFAM, Clec16a, and E-cadherin promoters, and recruits the H3K4 methyltransferase Set9 to convert RNA polymerase II from initiation to elongation mode at the insulin locus [PMID:8524276, PMID:10636926, PMID:16141209, PMID:26657766]. PDX1 nuclear availability is controlled by SUMO-1 modification, JNK-dependent nuclear export via a defined NES, sequestration in palmitate-induced stress granules, and phosphorylation by GSK3 and CK2, while the SPOP/PCIF1 E3 adaptor targets it for proteasomal degradation through a phosphorylation-sensitive degron whose crystal structure has been resolved [PMID:14633849, PMID:33569632, PMID:30879985, PMID:30449689]. Complete PDX1 loss causes pancreatic agenesis and haploinsufficiency leads to impaired beta-cell mass, ER stress susceptibility, defective mitophagy (via Clec16a–Nrdp1), reduced mitochondrial biogenesis (via TFAM), and circadian de-repression of NF-κB inflammatory programs, while gain-of-function drives acinar-to-ductal metaplasia through Stat3 [PMID:8631275, PMID:19855005, PMID:26085571, PMID:19656489, PMID:38171340, PMID:16751181]. Homozygous and compound heterozygous PDX1 mutations cause neonatal diabetes and pancreatic agenesis in humans [PMID:20009086, PMID:30930126].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Before this work it was unknown how PDX1 achieved target-gene specificity; demonstration that PDX1 forms cooperative DNA-binding complexes with Pbx via its conserved FPWMK pentapeptide and homeodomain N-terminal arm established the cofactor-dependent binding paradigm for PDX1 target selection.\",\n      \"evidence\": \"In vitro DNA-binding assays, co-IP, and FPWMK/homeodomain mutagenesis on somatostatin promoter elements\",\n      \"pmids\": [\"8524276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Pbx–PDX1 cooperative complex not resolved\", \"In vivo relevance of FPWMK motif not tested genetically\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Whether PDX1 was essential for pancreas formation was unresolved; knockout mice lacking pdx-1 showed pancreatic agenesis with only rudimentary dorsal bud outgrowth, establishing PDX1 as indispensable for pancreatic progenitor proliferation and differentiation.\",\n      \"evidence\": \"Gene targeting (constitutive knockout mouse), histology, immunostaining, lacZ reporter\",\n      \"pmids\": [\"8631275\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous versus non-autonomous roles not distinguished\", \"Which downstream targets mediate pancreatic outgrowth arrest unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"The structural basis for PDX1 transactivation was undefined; mapping identified three conserved N-terminal subdomains required for synergistic insulin promoter activation with E2A bHLH factors, and upstream USF/E-box-dependent regulation of the PDX1 gene itself was demonstrated in vivo.\",\n      \"evidence\": \"GAL4-chimera mutagenesis in betaTC3, transgenic reporter mice with USF site mutations\",\n      \"pmids\": [\"9199333\", \"8567692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of all cofactors engaging the three subdomains unknown\", \"Whether USF is the sole upstream regulator in vivo untested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"How PDX1 reaches the nucleus was unknown; identification of a novel NLS within homeodomain helix 3, plus reconstitution of cooperative Pbx1–Prep1–PDX1 and Pax6–PDX1 complexes on the somatostatin enhancer, defined the nuclear targeting and combinatorial logic of PDX1 at endocrine-specific genes.\",\n      \"evidence\": \"GFP-tagged deletion/point mutants in COS-7 cells; EMSA with recombinant Pbx1/Prep1/PDX1; reporter assays with Pax6\",\n      \"pmids\": [\"10429201\", \"9933599\", \"10094480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"NLS importin partner not identified\", \"Relative contribution of each cofactor complex in vivo unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Whether PDX1 alone could activate high-level insulin transcription was unclear; combinatorial expression showed that PDX1 with BETA2/NeuroD and E2A synergistically activated insulin ~160-fold, and that the PDX1 transactivation domain confers beta-cell-specific, glucose-responsive activity that heterologous activation domains cannot replace.\",\n      \"evidence\": \"Combinatorial transfection in non-beta cells; GAL4-substituted enhancer reporters in beta and non-beta lines\",\n      \"pmids\": [\"10636926\", \"11117522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Glucose-sensing mechanism of PDX1 transactivation domain unresolved\", \"Direct physical contacts between PDX1 and BETA2 not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The in vivo consequences of partial PDX1 loss were uncharacterized; haploinsufficient mice showed impaired GSIS, reduced GLUT2, defective mitochondrial NAD(P)H generation, increased beta-cell apoptosis with reduced Bcl-XL/Bcl-2, and failure of beta-cell mass expansion, while SUMO-1 modification was shown to promote PDX1 nuclear retention and transcriptional activity.\",\n      \"evidence\": \"Pdx1+/- mice with perfused pancreas, NAD(P)H imaging, TUNEL, caspase-3, Western blot; co-IP and RNAi for SUMO-1 in beta cells\",\n      \"pmids\": [\"11781323\", \"12697734\", \"12488243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SUMO-1 conjugation site(s) on PDX1 not mapped\", \"Whether apoptosis is cell-autonomous or secondary to metabolic stress unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The signaling pathways upstream of PDX1 in beta-cell mass regulation were unknown; genetic epistasis showed that Pdx1 transgene rescues beta-cell mass and prevents diabetes in Irs2-/- mice, placing PDX1 downstream of IRS2/insulin signaling.\",\n      \"evidence\": \"Irs2-/- × Pdx1 transgenic and Pdx1+/- genetic crosses, glucose tolerance, histology\",\n      \"pmids\": [\"11994408\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical mechanism linking IRS2 signaling to PDX1 expression/stability not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"How oxidative stress impairs PDX1 function was unknown; identification of a functional NES (aa 82–94) and demonstration that JNK-dependent phosphorylation triggers CRM1-mediated nuclear export of PDX1 established a regulated nucleo-cytoplasmic shuttling mechanism.\",\n      \"evidence\": \"GFP-PDX1 live imaging, leptomycin B blockade, dominant-negative JNK, NES deletion mapping in HIT-T15 cells\",\n      \"pmids\": [\"14633849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific JNK phosphorylation site(s) on PDX1 not identified\", \"Whether this mechanism operates in human islets not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The degradation machinery for PDX1 was unidentified; PCIF1/SPOP was discovered as a PDX1-interacting protein that alters its subnuclear distribution and inhibits its transactivation, initiating understanding of PDX1 proteostasis.\",\n      \"evidence\": \"Yeast two-hybrid identification, co-IP, reporter assays in MIN6\",\n      \"pmids\": [\"15121856\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SPOP mediates PDX1 ubiquitination and degradation not directly shown at this stage\", \"Endogenous interaction stoichiometry unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The chromatin mechanism by which PDX1 activates insulin transcription was unknown; PDX1 was shown to recruit the H3K4 methyltransferase Set9 to the insulin promoter, linking PDX1 occupancy to histone methylation and RNA pol II elongation.\",\n      \"evidence\": \"Co-IP of PDX1–Set9, ChIP for H3K4me2 and pol II isoforms, siRNA knockdown of PDX1\",\n      \"pmids\": [\"16141209\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Set9 is required for all PDX1 target genes or only insulin unknown\", \"Structural basis of PDX1–Set9 interaction unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Consequences of ectopic/sustained PDX1 expression were undefined; constitutive PDX1 in all pancreatic lineages caused acinar-to-ductal metaplasia through cell-autonomous Stat3 activation, revealing a dosage-dependent oncogenic potential.\",\n      \"evidence\": \"Transgenic CAG-PDX1 mice, genetic Stat3 knockout epistasis, histology\",\n      \"pmids\": [\"16751181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PDX1 activates Stat3 (direct transcriptional target vs. signaling) not resolved\", \"Relevance to human pancreatic cancer initiation uncertain\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"PDX1's role beyond insulin gene regulation in beta-cell homeostasis was unclear; three studies collectively showed that PDX1 directly activates TFAM to maintain mitochondrial biogenesis and respiration, regulates a broad ER function gene program protecting against ER stress, and that excessive autophagy contributes to Pdx1-deficient beta-cell death.\",\n      \"evidence\": \"ChIP at TFAM promoter with adenoviral TFAM rescue; ChIP + microarray in Pdx1+/- and Min6 siRNA; Pdx1+/- × Becn1+/- genetic cross with autophagy inhibitors\",\n      \"pmids\": [\"19656489\", \"19855005\", \"19654319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ER stress and mitochondrial defects are independent or interconnected consequences of PDX1 loss not resolved\", \"Autophagy pathway specificity not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Whether homeodomain integrity is needed for PDX1 transactivation independently of DNA binding was untested; the E178G neonatal-diabetes mutation was shown to impair transactivation without affecting nuclear localization or chromatin occupancy, dissociating binding from activation.\",\n      \"evidence\": \"Genetic analysis of consanguineous family; recombinant protein functional assays in cell lines\",\n      \"pmids\": [\"20009086\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which E178G disrupts transactivation despite normal occupancy unknown\", \"Single family reported\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Post-translational regulation of PDX1 by kinases beyond JNK was poorly characterized; CK2 was identified as a kinase phosphorylating PDX1 at Thr231/Ser232, modulating insulin promoter activity.\",\n      \"evidence\": \"In vitro kinase assay, phosphosite mutagenesis, insulin promoter reporters, CK2 inhibitor\",\n      \"pmids\": [\"20339896\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of CK2 phosphorylation not validated\", \"Interplay with SPOP degron phosphorylation not examined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"How PDX1 protein stability is maintained was unclear; RB was found to bind PDX1 via a conserved RB-interaction motif, stabilizing it against proteasomal degradation, and forced Pdx1 expression from the Neurog3 stage was shown to convert alpha cells to functional beta cells in vivo.\",\n      \"evidence\": \"Co-IP, RIM mutagenesis, proteasome inhibitor, RB conditional knockout; conditional Pdx1 transgene with Neurog3-Cre lineage tracing\",\n      \"pmids\": [\"21399612\", \"21852533\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RB protection is direct or involves competition with SPOP not tested\", \"Efficiency and completeness of alpha-to-beta conversion in adult animals unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The genome-wide direct target repertoire of PDX1 in primary islets was undefined; ChIP-seq in human and mouse islets revealed a conserved cistrome enriched for endocrine function, metabolic, and cell-survival genes.\",\n      \"evidence\": \"ChIP-seq in human and mouse islets with evolutionary conservation analysis\",\n      \"pmids\": [\"22322596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional validation of most identified targets not performed\", \"Condition-dependent (e.g. glucose-stimulated) binding changes not captured\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"PDX1's control of mitochondrial quality and pancreatic lineage specification was incompletely understood; PDX1 was shown to regulate mitophagy through transcriptional control of Clec16a–Nrdp1, to directly activate E-cadherin for epithelial morphogenesis, and to cooperate genome-wide with Sox9 to activate pancreatic and repress intestinal gene programs.\",\n      \"evidence\": \"ChIP-seq at Clec16a with adenoviral rescue and mitophagy assays; ChIP at E-cadherin promoter with Pdx1-/- embryo analysis; ChIP-seq for Pdx1 and Sox9 with conditional knockouts\",\n      \"pmids\": [\"26085571\", \"26657766\", \"26440894\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Clec16a is rate-limiting for mitophagy in human islets unknown\", \"Mechanism of Sox9–PDX1 cooperative binding not structurally defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The structural basis for SPOP-mediated PDX1 degradation was unresolved; a crystal structure of the SPOP MATH domain bound to PDX1 residues 223–233 showed phosphorylation within the degron reduces SPOP binding, providing a mechanistic switch for PDX1 stability; concurrently, PDX1–ATF4/ATF5 complexes were found to co-occupy CARE motifs at stress/apoptosis genes.\",\n      \"evidence\": \"Crystal structure, ITC, NMR for SPOP–PDX1; co-IP, ChIP-seq, RNAseq, and Gpt2 knockout for ATF complexes\",\n      \"pmids\": [\"30449689\", \"30174228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of kinase(s) that phosphorylate the SPOP degron in vivo unknown\", \"Whether ATF4/ATF5 partnership is stress-specific or constitutive not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The pathogenic kinase targeting PDX1 under glucotoxicity was unidentified; GSK3 was shown to phosphorylate PDX1 in diabetic islets, and GSK3 inhibition rescued GSIS in human islets; separately, iPSC-modeled transactivation domain mutations (P33T, C18R) confirmed structure–function requirements for PDX1 in human beta-cell differentiation.\",\n      \"evidence\": \"Phosphoproteomics of diabetic mouse islets, GSK3 inhibitor rescue in human islets; isogenic iPSC differentiation with ChIP-seq and RNA profiling\",\n      \"pmids\": [\"30879985\", \"30930126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific GSK3 phosphosites on PDX1 not all mapped\", \"Whether GSK3 phosphorylation feeds into SPOP-dependent degradation not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"How lipotoxicity disrupts PDX1 nuclear function was mechanistically undefined; palmitate was shown to trap PDX1 in cytoplasmic stress granules via PI3K/EIF2α-dependent disruption of nucleocytoplasmic transport, and disruption of stress granule assembly restored PDX1 nuclear localization and beta-cell function.\",\n      \"evidence\": \"Mass spectrometry of stress granule components, immunofluorescence, PI3K/EIF2α inhibitors, TIA1 knockout mice\",\n      \"pmids\": [\"33569632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether stress granule trapping occurs with unsaturated fatty acids unknown\", \"Direct RNA targets of PDX1 within stress granules not characterized\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Whether PDX1 integrates circadian and inflammatory programs was unknown; PDX1 was found to silence NF-κB at circadian enhancers through long-range chromatin contacts involving SIN3A, and Bmal1 ablation disrupted genome-wide PDX1 binding, establishing PDX1 as a circadian-inflammatory gatekeeper in beta cells.\",\n      \"evidence\": \"Single-cell ATAC-seq, ChIP-seq, Hi-C, Pdx1 hypomorphic mice, Bmal1 beta-cell knockout, IL-1β receptor antagonism\",\n      \"pmids\": [\"38171340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether circadian PDX1 binding dynamics are direct or Bmal1-dependent not fully separated\", \"SIN3A recruitment mechanism to PDX1-bound sites not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: (1) the complete phosphorylation code integrating GSK3, CK2, JNK, and SPOP-degron phosphorylation into a unified PDX1 stability/localization model; (2) the structural basis for PDX1 cooperative interactions with its diverse cofactor partners; (3) which PDX1 chromatin targets are dynamically regulated by glucose versus constitutively bound; and (4) the mechanism by which homeodomain mutations impair transactivation despite preserved DNA occupancy.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No integrated phosphorylation map of PDX1\", \"No full-length PDX1 structure available\", \"Glucose-responsive versus constitutive target binding not systematically resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 7, 8, 9, 10, 17, 25, 27, 28]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 9, 10, 17, 18, 19, 20, 25, 26, 28, 30, 32, 35]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 12, 14, 33]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 9, 10, 17, 25, 27, 30, 32, 35]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 24, 27, 28]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [11, 19, 31]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [15, 21, 30]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [21, 26]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [12, 23, 29]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13, 18, 31]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [19, 26, 34]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PBX1\", \"PREP1\", \"PAX6\", \"NEUROD1\", \"SETD7\", \"SPOP\", \"RB1\", \"ATF4\"],\n    \"other_free_text\": []\n  }\n}\n```"}